Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NVTA

Invitae (NVTA) Stock Price, News & Analysis

Invitae logo

About Invitae Stock (NYSE:NVTA)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.02
$0.02
Volume
75 shs
Average Volume
23.72 million shs
Market Capitalization
$80.10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invitae and its competitors with MarketBeat's FREE daily newsletter.

NVTA Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Labcorp to acquire Invitae assets for $239 million
Labcorp wins $239M bid for bankrupt Invitae
See More Headlines

NVTA Stock Analysis - Frequently Asked Questions

Invitae Co. (NYSE:NVTA) issued its quarterly earnings results on Tuesday, May, 9th. The medical research company reported ($0.37) earnings per share for the quarter, beating analysts' consensus estimates of ($0.41) by $0.04. Invitae's revenue was down 5.1% on a year-over-year basis.

Invitae (NVTA) raised $76 million in an initial public offering on Thursday, February 12th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan acted as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invitae investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), CrowdStrike (CRWD), Teladoc Health (TDOC) and PayPal (PYPL).

Company Calendar

Last Earnings
5/09/2023
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NYSE:NVTA
CIK
1501134
Fax
N/A
Employees
1,700
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.11 billion
Net Margins
-299.14%
Pretax Margin
-301.93%
Return on Equity
-6,100.71%
Return on Assets
-19.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.39
Quick Ratio
2.25

Sales & Book Value

Annual Sales
$481.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
267,010,000
Free Float
284,373,000
Market Cap
$80.10 thousand
Optionable
Optionable
Beta
1.59

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:NVTA) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners